Catalyst event

AprilBio Co Ltd (397030)

From KRX Bio Technology Transfer Index (KBIOTT)

AprilBio signed a technology license-in agreement with Curigin for a dual-target siRNA-based metabolic-disease drug candidate.

Korean translation

에이프릴바이오가 큐리진과 이중표적 siRNA 기반 대사질환 치료제 후보물질의 기술도입 계약을 체결함.